DE60135261D1 - Arzneimittel, welches ein Peptid kleiner oder mittlerer Grösse enthält - Google Patents

Arzneimittel, welches ein Peptid kleiner oder mittlerer Grösse enthält

Info

Publication number
DE60135261D1
DE60135261D1 DE60135261T DE60135261T DE60135261D1 DE 60135261 D1 DE60135261 D1 DE 60135261D1 DE 60135261 T DE60135261 T DE 60135261T DE 60135261 T DE60135261 T DE 60135261T DE 60135261 D1 DE60135261 D1 DE 60135261D1
Authority
DE
Germany
Prior art keywords
small
peptide
medium size
medicament containing
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60135261T
Other languages
English (en)
Inventor
Wayne Woodrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Patents Exploitation Co BV
Original Assignee
Patents Exploitation Co BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patents Exploitation Co BV filed Critical Patents Exploitation Co BV
Application granted granted Critical
Publication of DE60135261D1 publication Critical patent/DE60135261D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60135261T 2000-02-04 2001-02-02 Arzneimittel, welches ein Peptid kleiner oder mittlerer Grösse enthält Expired - Fee Related DE60135261D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00102429 2000-02-04

Publications (1)

Publication Number Publication Date
DE60135261D1 true DE60135261D1 (de) 2008-09-25

Family

ID=8167782

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135261T Expired - Fee Related DE60135261D1 (de) 2000-02-04 2001-02-02 Arzneimittel, welches ein Peptid kleiner oder mittlerer Grösse enthält

Country Status (4)

Country Link
US (1) US6949509B2 (de)
JP (1) JP2001233787A (de)
AT (1) ATE404214T1 (de)
DE (1) DE60135261D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
AU2006326418A1 (en) * 2005-12-16 2007-06-21 Argolyn Bioscience, Inc. Non-natural amino acids and neurotensin analogues thereof
PL2389923T3 (pl) * 2010-05-19 2013-06-28 Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A Trwały, gotowy do użycia iniekcyjny preparat paracetamolu
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
JP7030517B2 (ja) 2015-01-07 2022-03-07 トライジェミナ， インコーポレイテッド マグネシウム含有オキシトシン製剤および使用の方法
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
WO2019180561A1 (en) 2018-03-20 2019-09-26 Mankind Pharma Ltd. Stable pharmaceutical composition of vasopressin
WO2024100032A1 (en) * 2022-11-09 2024-05-16 Xellia Pharmaceuticals Aps Vasopressin formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853375A (en) * 1987-09-16 1989-08-01 The Trustees Of The University Of Pennsylvania Method of lowering intraocular (eye) pressure
SE9300105D0 (sv) * 1993-01-15 1993-01-15 Kabi Pharmacia Ab Stable protein solution
JPH09502425A (ja) 1993-06-29 1997-03-11 フエリング ビー ヴイ デスモプレッシン鼻腔投与用組成
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin

Also Published As

Publication number Publication date
US6949509B2 (en) 2005-09-27
US20010027177A1 (en) 2001-10-04
ATE404214T1 (de) 2008-08-15
JP2001233787A (ja) 2001-08-28

Similar Documents

Publication Publication Date Title
DE60135261D1 (de) Arzneimittel, welches ein Peptid kleiner oder mittlerer Grösse enthält
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
DE60015112D1 (de) Peptidextrakt aus lupinen und pharmazeutische oder kosmetische oder pharmaco-nahrungsmittel zusammensetzung, die so ein extrakt enthalten
HRP20041152B1 (en) Pharmaceutical formulations
DE69115229T2 (de) Arzneimittel.
HUP0300855A3 (en) Peptidmomimetic protease inhibitors, pharmaceutical compositions and their use
MX9601150A (es) Uso de un antagonista del peptido derivado del gen de calcitonina para el tratamiento del erojecimiento cutaneo de origen neurogenico y composicion obtenida.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
NO992102L (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
WO2002060422A3 (en) Treatment of diabetes mellitus using vardenafil
HUP9903931A2 (hu) Indolopirrolokarbazolok citotoxikus aminocukor- és más rokon jellegű cukorszármazékai
WO2003016335A3 (en) Irreversible cysteine protease inhibitors of legumain
DK0984982T3 (da) LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
BG103714A (en) Pararacetamol-containing tablet
ES2185660T3 (es) Nuevo uso de dexmedetomidina.
HUP9904109A2 (hu) Külsőleg használandó helyi érzéstelenítő
BR0211186A (pt) peptìdeos e uso dos mesmos no escurecimento da pele
DE69102704D1 (de) Orales, melatonin enthaltendes arzneimittel.
NO913035D0 (no) (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.
WO2002012198A3 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
NO20040702L (no) Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
ATE257374T1 (de) Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee